Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-PLUS: double-blind, randomised, placebo-controlled phase 3 clinical trial
María Eugenia Toledo-Romaní, Mayra García-Carmenate, Carmen Valenzuela-Silva, Waldemar Baldoquín-Rodríguez, Marisel Martínez-Pérez, Meiby Rodríguez-González, Beatriz Paredes-Moreno, Ivis Mendoza-Hernández, Raúl González-Mujica, Oscar Samón-Tabio, Pablo Velazco-Villares, Juan Pablo Bacallao-Castillo, Ernesto Licea-Martín, Misladys Rodríguez-Ortega, Nuris Herrera-Marrero, Esperanza Caballero-González, Liudmila Egües-Torres, Reinaldo Duartes-González, Serguey García-Blanco, Suzette Pérez-Cabrera, Santos Huete-Ferreira, Kirenia Idalmis-Cisnero, Omayda Fonte-Galindo, Dania Meliá-Pérez, Ivonne Rojas-Remedios, View ORCID ProfileDelaram Doroud, Mohammad Mehdi Gouya, Alireza Biglari, Patrick Van der Stuyft, Sonsire Fernández-Castillo, Yanet Climent-Ruiz, Yury Valdes-Balbín, Dagmar García-Rivera, View ORCID ProfileVicente Verez-Bencomo, the SOBERANA Phase 3 team
doi: https://doi.org/10.1101/2021.10.31.21265703
María Eugenia Toledo-Romaní
1“Pedro Kourí” Tropical Medicine Institute. Av “Novia del Mediodía”, Kv 6 1/2, La Lisa, Habana, 11400, Cuba
Mayra García-Carmenate
2Havana Hygiene and Epidemiology Center, Havana, Cuba
Carmen Valenzuela-Silva
3Cybernetics, Mathematics and Physics Institute. 15th St #55, Vedado, Plaza de la Revolución, Havana10400, Cuba
Waldemar Baldoquín-Rodríguez
1“Pedro Kourí” Tropical Medicine Institute. Av “Novia del Mediodía”, Kv 6 1/2, La Lisa, Habana, 11400, Cuba
Marisel Martínez-Pérez
4Finlay Vaccine Institute. 21st Ave. Nº 19810 between 198 and 200 St, Atabey, Playa, Havana, Cuba
Meiby Rodríguez-González
4Finlay Vaccine Institute. 21st Ave. Nº 19810 between 198 and 200 St, Atabey, Playa, Havana, Cuba
Beatriz Paredes-Moreno
4Finlay Vaccine Institute. 21st Ave. Nº 19810 between 198 and 200 St, Atabey, Playa, Havana, Cuba
Ivis Mendoza-Hernández
5National Coordinating Center for Clinical Trials. 5th Ave and 62, Miramar, Playa, Havana, Cuba
Raúl González-Mujica
4Finlay Vaccine Institute. 21st Ave. Nº 19810 between 198 and 200 St, Atabey, Playa, Havana, Cuba
Oscar Samón-Tabio
6“José Antonio Echevarría” Technological University, Havana, Cuba
Pablo Velazco-Villares
7UCT Geocuba Research and Consulting, Havana, Cuba
Juan Pablo Bacallao-Castillo
7UCT Geocuba Research and Consulting, Havana, Cuba
Ernesto Licea-Martín
4Finlay Vaccine Institute. 21st Ave. Nº 19810 between 198 and 200 St, Atabey, Playa, Havana, Cuba
Misladys Rodríguez-Ortega
1“Pedro Kourí” Tropical Medicine Institute. Av “Novia del Mediodía”, Kv 6 1/2, La Lisa, Habana, 11400, Cuba
Nuris Herrera-Marrero
1“Pedro Kourí” Tropical Medicine Institute. Av “Novia del Mediodía”, Kv 6 1/2, La Lisa, Habana, 11400, Cuba
Esperanza Caballero-González
4Finlay Vaccine Institute. 21st Ave. Nº 19810 between 198 and 200 St, Atabey, Playa, Havana, Cuba
Liudmila Egües-Torres
2Havana Hygiene and Epidemiology Center, Havana, Cuba
Reinaldo Duartes-González
8Municipal Health Department, Centro Habana, Havana, Cuba
Serguey García-Blanco
9Municipal Health Department, La Lisa, Havana, Cuba
Suzette Pérez-Cabrera
10Municipal Health Department, 10 de Octubre, Havana, Cuba
Santos Huete-Ferreira
11Municipal Health Department, Habana Vieja Havana, Cuba
Kirenia Idalmis-Cisnero
12Municipal Health Department, Cerro, Havana, Cuba
Omayda Fonte-Galindo
13Municipal Health Department, Marianao, Havana, Cuba
Dania Meliá-Pérez
14Municipal Health Department, Playa, Havana, Cuba
Ivonne Rojas-Remedios
15Municipal Health Department, Plaza Havana, Cuba
Delaram Doroud
16Pasteur Institute of Iran. No. 69, Pasteur Ave., Tehran 1316943551, Islamic Republic of Iran
Mohammad Mehdi Gouya
17Iran University of Medical Science, Teheran, Iran
Alireza Biglari
16Pasteur Institute of Iran. No. 69, Pasteur Ave., Tehran 1316943551, Islamic Republic of Iran
Patrick Van der Stuyft
18Gent University, Gent, Belgium
Sonsire Fernández-Castillo
4Finlay Vaccine Institute. 21st Ave. Nº 19810 between 198 and 200 St, Atabey, Playa, Havana, Cuba
Yanet Climent-Ruiz
4Finlay Vaccine Institute. 21st Ave. Nº 19810 between 198 and 200 St, Atabey, Playa, Havana, Cuba
Yury Valdes-Balbín
4Finlay Vaccine Institute. 21st Ave. Nº 19810 between 198 and 200 St, Atabey, Playa, Havana, Cuba
Dagmar García-Rivera
4Finlay Vaccine Institute. 21st Ave. Nº 19810 between 198 and 200 St, Atabey, Playa, Havana, Cuba
Vicente Verez-Bencomo
4Finlay Vaccine Institute. 21st Ave. Nº 19810 between 198 and 200 St, Atabey, Playa, Havana, Cuba
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted August 03, 2022.
Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-PLUS: double-blind, randomised, placebo-controlled phase 3 clinical trial
María Eugenia Toledo-Romaní, Mayra García-Carmenate, Carmen Valenzuela-Silva, Waldemar Baldoquín-Rodríguez, Marisel Martínez-Pérez, Meiby Rodríguez-González, Beatriz Paredes-Moreno, Ivis Mendoza-Hernández, Raúl González-Mujica, Oscar Samón-Tabio, Pablo Velazco-Villares, Juan Pablo Bacallao-Castillo, Ernesto Licea-Martín, Misladys Rodríguez-Ortega, Nuris Herrera-Marrero, Esperanza Caballero-González, Liudmila Egües-Torres, Reinaldo Duartes-González, Serguey García-Blanco, Suzette Pérez-Cabrera, Santos Huete-Ferreira, Kirenia Idalmis-Cisnero, Omayda Fonte-Galindo, Dania Meliá-Pérez, Ivonne Rojas-Remedios, Delaram Doroud, Mohammad Mehdi Gouya, Alireza Biglari, Patrick Van der Stuyft, Sonsire Fernández-Castillo, Yanet Climent-Ruiz, Yury Valdes-Balbín, Dagmar García-Rivera, Vicente Verez-Bencomo, the SOBERANA Phase 3 team
medRxiv 2021.10.31.21265703; doi: https://doi.org/10.1101/2021.10.31.21265703
Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-PLUS: double-blind, randomised, placebo-controlled phase 3 clinical trial
María Eugenia Toledo-Romaní, Mayra García-Carmenate, Carmen Valenzuela-Silva, Waldemar Baldoquín-Rodríguez, Marisel Martínez-Pérez, Meiby Rodríguez-González, Beatriz Paredes-Moreno, Ivis Mendoza-Hernández, Raúl González-Mujica, Oscar Samón-Tabio, Pablo Velazco-Villares, Juan Pablo Bacallao-Castillo, Ernesto Licea-Martín, Misladys Rodríguez-Ortega, Nuris Herrera-Marrero, Esperanza Caballero-González, Liudmila Egües-Torres, Reinaldo Duartes-González, Serguey García-Blanco, Suzette Pérez-Cabrera, Santos Huete-Ferreira, Kirenia Idalmis-Cisnero, Omayda Fonte-Galindo, Dania Meliá-Pérez, Ivonne Rojas-Remedios, Delaram Doroud, Mohammad Mehdi Gouya, Alireza Biglari, Patrick Van der Stuyft, Sonsire Fernández-Castillo, Yanet Climent-Ruiz, Yury Valdes-Balbín, Dagmar García-Rivera, Vicente Verez-Bencomo, the SOBERANA Phase 3 team
medRxiv 2021.10.31.21265703; doi: https://doi.org/10.1101/2021.10.31.21265703
Subject Area
Subject Areas
- Addiction Medicine (393)
- Allergy and Immunology (705)
- Anesthesia (197)
- Cardiovascular Medicine (2882)
- Dermatology (247)
- Emergency Medicine (432)
- Epidemiology (12622)
- Forensic Medicine (10)
- Gastroenterology (813)
- Genetic and Genomic Medicine (4483)
- Geriatric Medicine (409)
- Health Economics (717)
- Health Informatics (2868)
- Health Policy (1059)
- Hematology (379)
- HIV/AIDS (911)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4251)
- Nursing (228)
- Nutrition (622)
- Oncology (2226)
- Ophthalmology (634)
- Orthopedics (255)
- Otolaryngology (323)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1182)
- Primary Care Research (488)
- Public and Global Health (6829)
- Radiology and Imaging (1503)
- Respiratory Medicine (909)
- Rheumatology (431)
- Sports Medicine (376)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)